Albertsons Companies Inc
Change company Symbol lookup
Select an option...
ACI Albertsons Companies Inc
GMTX Gemini Therapeutics Inc
IIIN Insteel Industries Inc
KO Coca-Cola Co
MOD Modine Manufacturing Co
WABC Westamerica Bancorp
LUV Southwest Airlines Co
COF-K Capital One Financial Corp
NDAQ Nasdaq Inc
KEY-K KeyCorp
Go

Consumer Staples : Food & Staples Retailing | Mid Cap Value
Company profile

Albertsons Companies, Inc. is a food and drug retailer in the United States. The Company’s stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It operates approximately 2,278 stores across 34 states and the District of Columbia under 20 banners including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets and Balducci's Food Lovers Market. The Company operates approximately 1,725 pharmacies, 1,313 in-store branded coffee shops, 399 associated fuel centers, 22 dedicated distribution centers, 20 manufacturing facilities and various digital platforms. In addition, the Company also collaborates with third parties, including Instacart for rush delivery as well as DoorDash for delivery of its prepared and ready-to-eat offerings.

Closing Price
$35.84
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
1,170,346
0

AbCellera to Present Virtually at the BofA Securities - Tech Solutions for Drug Discovery Conference

4:17 pm ET September 10, 2021 (BusinessWire) Print

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present virtually at the BofA Securities - Tech Solutions for Drug Discovery Conference on Monday, September 20, 2021, at 9:00 a.m. Pacific Time.

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210910005540/en/

SOURCE: AbCellera

Inquiries 
Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774
Business Development: Neil Berkley, Ph.D.; bd@abcellera.com, +1(604)559-9005
Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116
comtex tracking

COMTEX_393128530/1006/2021-09-10T16:17:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.